State Street SPDR S&P Biotech ETF (XBI) is an exchange-traded fund listed on NYSE ARCA, issued by SPDR. It last traded at $154.97 (+1.92% on the day), within a 52-week range of $106.30 to $169.89. It is an equity fund with 165 holdings, $10.76B in assets under management and an expense ratio of 0.35%. It launched on Jan 31, 2006.
SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series…
ETF data for XBI: Summary · AI Insight · News · Holdings